U.Va. Engineering Alum’s Lifesaving Innovation Now Available to the Public

Photo: http://photos.prnewswire.com/prnh/20130128/NY48939

An epinephrine auto-injector developed by an innovative U.Va. alumnus is now available in U.S. pharmacies.

Evan Edwards (Mechanical Engineering ’02, Systems Engineering ’04) and twin brother Eric are the founders of Richmond-based Intelliject Inc. Both sufferers of severe allergies, they combined their respective engineering and medical educations to develop an improved epinephrine self-injector for the treatment of severe allergic reactions, such as those affecting more than 6 million people at risk for anaphylaxis in the U.S.

Their product, Auvi-Q™, is about the size of a credit card, has a self-retractable needle, and provides audible instructions and visual cues for self-administration. Intelliject licensed Auvi-Q™ to Sanofi North America pharmaceuticals for commercialization in the U.S. It is now available at thousands of U.S. pharmacies with a doctor’s prescription.

Related links:


Email Facebook Twitter Linkedin

Comments are closed.